- £87.79m
- £77.12m
- £0.93m
REG - AIM - AIM Notice - 13/11/2024
AnnouncementREG-4basebio Plc: Completion of Strategic Investment
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG-4basebio Plc: Half-year Report
AnnouncementREG-4basebio Plc: Update re Equity Issuance, Secondary Sale and the board
AnnouncementREG-4basebio Plc: Strategic Advisory Board & Appointment of Director
AnnouncementREG-4basebio Plc: £40.0m Equity Issuance and £29.4m Secondary Sale
AnnouncementREG - AIM - AIM Notice - 19/07/2024
AnnouncementREG-4basebio Plc: Employee Long Term Incentive Plan and Issue of Equity
AnnouncementREG-4basebio Plc: Result of AGM
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG-4basebio Plc: Final Results and Notice of AGM
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG-4basebio Plc: 4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program
AnnouncementREG-4basebio Plc: 4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine
Announcement